The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-01-22
DOI
10.3389/fendo.2018.00768
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
- (2018) Lorenzo Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Combination Treatment with Bromocriptine and Metformin in Patients with Bromocriptine-Resistant Prolactinomas: Pilot Study
- (2018) Xiaohai Liu et al. World Neurosurgery
- Bromocriptine Induces Autophagy-Dependent Cell Death in Pituitary Adenomas
- (2017) Xin Geng et al. World Neurosurgery
- MAPK/JNK signaling: A potential autophagy regulation pathway
- (2015) Yuan-Yuan Zhou et al. BIOSCIENCE REPORTS
- mTOR: a pharmacologic target for autophagy regulation
- (2015) Young Chul Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- The pituitary TGFβ1 system as a novel target for the treatment of resistant prolactinomas
- (2015) M Victoria Recouvreux et al. JOURNAL OF ENDOCRINOLOGY
- Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline
- (2015) Shao Jian Lin et al. Oncotarget
- Autophagy: Renovation of Cells and Tissues
- (2011) Noboru Mizushima et al. CELL
- Resistance to dopamine agonists in prolactinoma is correlated with reduction of dopamine D2 receptor long isoform mRNA levels
- (2011) Satoko Shimazu et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
- (2011) Shlomo Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dopamine-Induced Apoptosis of Lactotropes Is Mediated by the Short Isoform of D2 Receptor
- (2011) Daniela Betiana Radl et al. PLoS One
- Diagnosis and management of pituitary adenomas
- (2010) Ranee R Lleva et al. CURRENT OPINION IN ONCOLOGY
- Ion Channels and Signaling in the Pituitary Gland
- (2010) Stanko S. Stojilkovic et al. ENDOCRINE REVIEWS
- Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behavior
- (2010) Zhe Bao Wu et al. JOURNAL OF NEURO-ONCOLOGY
- Bromocriptine and Dopamine Mediate Independent and Synergistic Apoptotic Pathways in Pituitary Cells
- (2010) F.B. Rowther et al. NEUROENDOCRINOLOGY
- The epidemiology and genetics of pituitary adenomas
- (2009) Adrian F. Daly et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Mammalian autophagy: core molecular machinery and signaling regulation
- (2009) Zhifen Yang et al. CURRENT OPINION IN CELL BIOLOGY
- Bromocriptine induces parapoptosis as the main type of cell death responsible for experimental pituitary tumor shrinkage
- (2009) Claudia Mariela Palmeri et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Apoptosis of Lactotrophs Induced by D2 Receptor Activation Is Estrogen Dependent
- (2008) Daniela B. Radl et al. NEUROENDOCRINOLOGY
- Genes Differentially Expressed in Prolactinomas Responsive and Resistant to Dopamine Agonists
- (2008) Vanessa Q. Passos et al. NEUROENDOCRINOLOGY
- 1-Nitropyrene (1-NP) induces apoptosis and apparently a non-apoptotic programmed cell death (paraptosis) in Hepa1c1c7 cells
- (2008) Nana Asare et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started